Dear Colleagues,
We are pleased to share with you excellent news about our participation in the III International Conference “Multidisciplinary Approach to the Provision of Obstetric and Gynecological Care”, which was held on December 8–9, 2023 in Astana, Kazakhstan.
AVVA took an active part in this iconic event. Our lecturer T.P. Zefirova, MD, Professor of the Department of Obstetrics and Gynecology at the Kazan State Medical Academy, a branch of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Health of Russia, made a report on the topic “Recurrent vulvovaginal candidiasis. New treatment possibilities.” She presented advanced scientific research and achievements in the treatment of this condition and received positive feedback and high praise from the listeners.
In the report, particular attention was paid to Ecofucin, the new medicine manufactured by AVVA. It represents an innovative solution in the treatment of vulvovaginal candidiasis. In the speech, scientific articles related to the study of Ecofucin were presented. We are proud that we can offer our colleagues a unique and effective drug.
Participation in the III International Conference allowed us not only to exchange experience with leading specialists in the field of obstetrics and gynecology, but also to demonstrate our progressiveness and contribution to the development of medical science. We appreciate the opportunity to be a part of this prestigious event and work towards improving healthcare.
We are pleased to share with you excellent news about our participation in the III International Conference “Multidisciplinary Approach to the Provision of Obstetric and Gynecological Care”, which was held on December 8–9, 2023 in Astana, Kazakhstan.
AVVA took an active part in this iconic event. Our lecturer T.P. Zefirova, MD, Professor of the Department of Obstetrics and Gynecology at the Kazan State Medical Academy, a branch of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Health of Russia, made a report on the topic “Recurrent vulvovaginal candidiasis. New treatment possibilities.” She presented advanced scientific research and achievements in the treatment of this condition and received positive feedback and high praise from the listeners.
In the report, particular attention was paid to Ecofucin, the new medicine manufactured by AVVA. It represents an innovative solution in the treatment of vulvovaginal candidiasis. In the speech, scientific articles related to the study of Ecofucin were presented. We are proud that we can offer our colleagues a unique and effective drug.
Participation in the III International Conference allowed us not only to exchange experience with leading specialists in the field of obstetrics and gynecology, but also to demonstrate our progressiveness and contribution to the development of medical science. We appreciate the opportunity to be a part of this prestigious event and work towards improving healthcare.
